Corvus Pharmaceuticals (CRVS)
(Delayed Data from NSDQ)
$2.17 USD
-0.06 (-2.69%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $2.18 +0.01 (0.46%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.12 | 0.00% |
Earnings Summary
For their last quarter, Corvus Pharmaceuticals (CRVS) reported earnings of -$0.12 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for CRVS's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.12 per share, reflecting a year-over-year increase of 14.29%.
Earnings History
Price & Consensus
Zacks News for CRVS
Down -18.35% in 4 Weeks, Here's Why Corvus (CRVS) Looks Ripe for a Turnaround
CRVS: What are Zacks experts saying now?
Zacks Private Portfolio Services